Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 27, 2010PLoS ONEOpen Access

Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)

View Full Paper
Ask AI
Bookmark
Share

Authors

CMCecilia MorganFred Hutch Cancer CenterZMZoe MoodieCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South AfricaHLHongli LiKunming Institute of Zoology

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Morgan et al. (2010) studied this question.

synapsesocial.com/papers/6a8a3d889be9d02581bd9a87https://doi.org/10.1371/journal.pone.0013579
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Phase IIA Randomized Clinical Trial of a Multiclade HIV-1 DNA Prime Followed by a Multiclade rAd5 HIV-1 Vaccine Boost in Healthy Adults (HVTN204)2011 · 140 citations
  2. 2CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials2010 · 13,621 citations
  3. 3Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus1998 · 328 citations
  4. 4CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials2010 · 2,338 citations
  5. 5DNA gag/Adenovirus Type 5 (Ad5) gag and Ad5 gag/Ad5 gag Vaccines Induce Distinct T-Cell Response Profiles2008 · 60 citations